NuFund Venture Group
VC Fund
San Diego, United States
NuFund Venture Group is a VC fund in San Diego focused on Biotechnology and Health Care. NuFund Venture Group formerly known as TCA-San Diego (TCA-SD) is the San Diego chapter of Tech Coast Angels.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 25%
- Fund size:
- $2.2M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries NuFund Venture Group invests in
Stages NuFund Venture Group invests in
Countries NuFund Venture Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $1.1M–$3.5M
- Pre-Seed
- $350k–$1.7M
Investment Focus
Industry
- Biotechnology 7 (44%)
- Health Care 5 (31%)
- Medical 3 (19%)
- Software 3 (19%)
- Medical Device 3 (19%)
Stage
- Seed 11 (69%)
- Pre-Seed 3 (19%)
- Series A 1 (6%)
- Venture - Series Unknown 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Cathy Pucher
Investor
|
Investor | Total investments: 0 | Find email | |
Dan Rosen
Member
|
Member | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cayuga Biotech
|
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayugais developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders. | $5M / Seed / Dec 11, 2025 | |
Big Rentals
|
Equipment rentals made easy with all-in-one rental software to help owners manage their business, grow sales, and accept online bookings. | $2.8M / Seed / Aug 15, 2025 | |
Synvect
|
Synvect is a biotech platform that creates safe and effective ways to eliminate disease-carrying mosquitoes by stopping their breeding. | $3M / Seed / Mar 11, 2025 | |
Streamfog
|
Ad breaks are a fundamental part of streaming services. But commercial breaks are a concept from the 50s that are disruptive and ineffective. Intrusive & excessive ads lower consumers retention rates and prevent high ad conversions.Streamfog is using Augmented Reality to place ads and virtual products in-content. No more intrusive ad breaksbut seamless placements. Imagine watching an interesting panel discussion on youtube and instead of having 3 ad breaks you will have AR ads within the 3D space of the recording. | $350K / Pre-Seed / Feb 01, 2025 | |
Trio Pharmaceuticals
|
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California. | $3.1M / Seed / Dec 03, 2024 | |
ROOK
|
ROOK is an API-first company that connects apps and software with useful, usable health data and valuable insights from their users’ wearables. | $1.7M / Pre-Seed / Mar 20, 2023 | |
CARI Health
|
Cari Health develops remote medication monitors that allow clinicians to prescribe medications and receive real-time reporting on medication levels. Its monitors are wireless sensors that are worn on the patient's skin and continuously send data about medication levels to the cloud.The company was founded in 2015, incorporated in 2021 and isheadquartered in San Diego, California. | $2.3M / Seed / Jan 10, 2023 | |
VerImmune
|
Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors. | $2.5M / Seed / Jul 27, 2022 | |
GroupSolver
|
GroupSolver® is the next generation online survey platform that incorporates AI, analytics automation and crowd intelligence. It works faster and deeper than a traditional survey. GroupSolver® helps managers and researchers from startups to Fortune 500 companies answer their burning why, what, and how questions quicker and with more confidence.By making Natural Language Processing (NLP) a cornerstone of our surveys, we quantify qualitative data and use it to enhance traditional statistical models. Customer segmentation, pricing, concept testing, brand perception and marketing campaign evaluation are just a few applications of our technology where we have achieved remarkable, practical insights. Using GroupSolver® does not require specialized data science knowledge. Our platform is user friendly and it works in real time without a human moderator, which dramatically decreases the amount of time it takes to answer your business questions. GroupSolver® is your partner when making fast, confident, and fact-based decisions is mission critical. | $2.5M / Venture - Series Unknown / May 31, 2022 | |
Indicio.tech
|
Indicio provides companies and markets the ability to create, develop, and launch new Trusted Data Ecosystems, marketplaces, and business models for the exchange of high value information and data assets. Specializing in financial, healthcare, and travel markets, Indicio provides customers with technology and a decentralized network to issue, hold,and verify data contained in encrypted digital credentials. With Indicio’s privacy-preserving software, companies can confirm data authenticity repeatedly and efficiently from its source without the expense or risk of direct integrations—resulting in a boost to their bottom-line profit and information privacy reputation. | $3.5M / Seed / Apr 25, 2022 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does NuFund Venture Group invest in?
NuFund Venture Group invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Pre-Seed stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is NuFund Venture Group's check size?
NuFund Venture Group typically joins rounds of $1.1M–$3.5M at Seed and $350k–$1.7M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NuFund Venture Group participates in.
How do I contact NuFund Venture Group?
Public channels for NuFund Venture Group include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NuFund Venture Group?
The team at NuFund Venture Group includes Cathy Pucher (Investor) and Dan Rosen (Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
